Could anti-obesity drugs transform healthcare? Jenny Chang, portfolio manager with Goldman Sachs Asset Management, separates the signal from the noise.
Our weekly newsletter with insights and intelligence from across the firm
By submitting this information, you agree to receive marketing emails from Goldman Sachs and accept our privacy policy. You can opt-out at any time.